These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26363430)

  • 1. Controlled release of copper from an intrauterine device using a biodegradable polymer.
    Ramakrishnan R; B B; Aprem AS
    Contraception; 2015 Dec; 92(6):585-8. PubMed ID: 26363430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifertility effectiveness of a novel copper-containing composite used in intrauterine contraceptive devices and the releasing behavior of cupric ions contained in the composite in rats.
    Peng X; Hu S; Meng T; Suo J; Xiong C
    Contraception; 2012 Oct; 86(4):413-8. PubMed ID: 22445435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auger and pixe microanalysis of intrauterine devices (IUDs).
    Foti A; Foti AM; Torrisi L
    Clin Exp Obstet Gynecol; 1990; 17(3-4):185-94. PubMed ID: 2292147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of copper corrosion from frameless copper IUDs after long-term in utero residence.
    Wildemeersch D; Sabbe PJ; Dowsett MG; Flexer V; Thompson P; Walker D; Thomas PA; Adriaens A
    Contraception; 2014 Oct; 90(4):454-9. PubMed ID: 25015534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper intrauterine device use by nulliparous women: review of side effects.
    Hubacher D
    Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the release behavior of cupric ion for three types of Cu-IUDs and indomethacin for medicated Cu-IUD in simulated uterine fluid.
    Jinying L; Ying L; Xuan G; Yanli G; Jianping L
    Contraception; 2008 Apr; 77(4):299-302. PubMed ID: 18342655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
    Elhag KM; Bahar AM; Mubarak AA
    J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of copper and indomethacin from intrauterine devices immersed in simulated uterine fluid.
    Zhou X; Li Y; Jiang X; Qiu L; Liu J
    Eur J Contracept Reprod Health Care; 2010 Jun; 15(3):205-12. PubMed ID: 20441407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reasons for removal of intrauterine devices among women in general practice].
    Kolding L; Majeed HG
    Ugeskr Laeger; 2013 Mar; 175(13):884-6. PubMed ID: 23582897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the release behaviors of cupric ions from metallic copper and a novel composite in simulated body fluid.
    Li J; Suo J; Huang X; Ye C; Wu X
    J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):172-9. PubMed ID: 17853420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of poly(ethylene oxide) in copper-containing composite used for intrauterine contraceptive devices.
    Wang H; Tang Y; Xia X; Lu Y
    J Mater Sci Mater Med; 2018 Jun; 29(7):92. PubMed ID: 29938314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine devices and adolescents.
    Gold MA; Johnson LM
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):464-9. PubMed ID: 18797269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.